INNOCAN PHARMA CORP (INNPF:OTCMKTS)
$2.5 -0.17 (-6.367%)
Analysed INNOCAN PHARMA CORP (INNPF:OTCMKTS) News Sources
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
09-02-2026
yahoo.com
Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board
27-02-2026
yahoo.com
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
27-02-2026
yahoo.com
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
11-03-2026
yahoo.com
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
16-03-2026
yahoo.com
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
31-03-2026
yahoo.com
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
31-03-2026
yahoo.com
Innocan Pharma Announces Closing of Additional Debenture
06-04-2026
yahoo.com
Innocan Pharma LPT-CBD is featured in Pain Medicine News
06-05-2026
yahoo.com
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
27-05-2026
yahoo.com
What is the current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS) is $2.5.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is $-0.17.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is -6.367%.
What is the most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is 53 out of 100.
What is the most recent average sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is .
SEC-8K** Filing Available For INNOCAN PHARMA CORP (INNPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.